Provided by Tiger Trade Technology Pte. Ltd.

Sable Offshore Corp.

4.77
-0.0650-1.35%
Volume:1.98M
Turnover:9.44M
Market Cap:914.88M
PE:-1.41
High:4.94
Open:4.88
Low:4.70
Close:4.83
52wk High:26.36
52wk Low:2.88
Shares:192.00M
Float Shares:137.00M
Volume Ratio:0.42
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3799
EPS(LYR):-4.1777
ROE:-103.21%
ROA:-14.02%
PB:2.32
PE(LYR):-1.14

Loading ...

How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy

Simply Wall St.
·
May 15

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

GlobeNewswire
·
May 14

MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control

prnewswire
·
May 14

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 12

Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns

TIPRANKS
·
May 08

Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
May 08

Sable Offshore (SOC) Receives a Rating Update from a Top Analyst

TIPRANKS
·
May 08

Sable Offshore Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Sable Offshore Q1 net loss widens 80% to $197.03 million; revenue swings to $1.27 million

Reuters
·
May 07

Sable Offshore Corp - Reports Q1 2026 Net Loss of $197.0 Mln

THOMSON REUTERS
·
May 07

Press Release: Sable Offshore Corp. Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Assessing Sable Offshore (SOC) Valuation After Upgraded Earnings Forecasts And Positive Analyst Rating

Simply Wall St.
·
May 06

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

GlobeNewswire
·
May 05

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

GlobeNewswire
·
May 02

Sable Offshore Corp call volume above normal and directionally bullish

TIPRANKS
·
May 01

Sable Offshore CEO Awarded $76 Million Despite No Oil Sales in 2025

MT Newswires Live
·
May 01

Sable Offshore announces annual shareholder meeting webcast

Reuters
·
May 01

Sable Offshore Corp Chairman & CEO James C. Flores's 2025 Total Compensation Was $75.9 Mln Including Stock Awards & Bonus - SEC Filing

THOMSON REUTERS
·
May 01

Radiopharm Theranostics Reports Business Update

GlobeNewswire
·
Apr 23

Sable Offshore Is Maintained at Buy by Jefferies

Dow Jones
·
Apr 23